Ford James S, Holmes James F, Jones Russell F
UC Davis Health, Department of Emergency Medicine, Sacramento, California.
Clin Pract Cases Emerg Med. 2020 Aug;4(3):332-335. doi: 10.5811/cpcem.2020.6.47856.
There is a growing body of literature detailing coronavirus 2019 (COVID-19) cardiovascular complications and hypercoagulability, although little has been published on venous or arterial thrombosis risk.
In this report, we present a single case of cardioembolic stroke in the setting of COVID-19 related myocarditis, diagnosed via cardiac magnetic resonance imaging and echocardiography. COVID-19 infection was confirmed via a ribonucleic acid polymerase chain reaction assay.
Further research is needed to evaluate the hypercoagulable state of patients with COVID-19 to determine whether prophylactic anticoagulation may be warranted to prevent intracardiac thrombi and cardioembolic disease in patients with COVID-19 related myocarditis.
尽管关于静脉或动脉血栓形成风险的报道较少,但越来越多的文献详细阐述了2019冠状病毒病(COVID-19)的心血管并发症和高凝状态。
在本报告中,我们介绍了1例在COVID-19相关心肌炎背景下发生的心源性栓塞性中风病例,通过心脏磁共振成像和超声心动图确诊。通过核糖核酸聚合酶链反应检测确诊为COVID-19感染。
需要进一步研究以评估COVID-19患者的高凝状态,以确定对于COVID-19相关心肌炎患者,预防性抗凝是否有助于预防心内血栓和心源性栓塞性疾病。